Articles by Disease (Basal Ganglia Diseases)

Brain Oxidative Markers in Stress: Possible New Drug Targets Against Neuroinflammation

Journal: Current Neuropharmacology
Volume: 2
Page: 183-189
Author(s): Jose L.M. Madrigal, Javier Caso, Olivia Hurtado, Ignacio Lizasoain, Maria A. Moro, Pedro Lorenzo and Juan C. Leza

[35S]GTPγS Autoradiography: A Powerful Functional Approach with Expanding Potential for Neuropharmacological Studies on Receptors Coupled to Gi Family of G Proteins

Journal: Current Neuropharmacology
Volume: 2
Page: 191-206
Author(s): Jarmo T. Laitinen

Endocannabinoids and their Involvement in the Neurovascular System

Journal: Current Neurovascular Research
Volume: 1
Page: 129-140
Author(s): Natalia Battista, Filomena Fezza and Mauro Maccarrone

Cardiovascular Alterations After Spinal Cord Injury: An Overview

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 2
Page: 133-148
Author(s): Guadalupe Bravo, Gabriel Guizar-Sahagun, Antonio Ibarra, David Centurion and Carlos M. Villalon

Therapeutic Options in Prevention and Treatment of Aspartoacylase Gene Mutation Resulting Abnormalities in Canavan Disease

Journal: Current Pharmacogenomics
Volume: 2
Page: 13-20
Author(s): Sankar Surendran, Stephen K. Tyring, Kimberlee Michals-Matalon and Reuben Matalon

Microglia:Neuroprotective and Neurotrophic Cells in the Central Nervous System

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4
Page: 65-84
Author(s): Kazuyuki Nakajima and Shinichi Kohsaka

Neuroprotection Abilities of Cytosolic Phospholipase A2 Inhibitors in Kainic acid-induced Neurodegeneration

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4
Page: 85-96
Author(s): Akhlaq A. Farooqui, Wei-Yi Ong and Lloyd A. Horrocks

The Controversial Role of Adenosine A2A Receptor Antagonists as Neuro-protective Agents

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4
Page: 35-45
Author(s): Patrizia Popoli, David Blum, Annita Pintor, Maria Teresa Tebano, Claudio Frank, Marco Gianfriddo, Maria Rosaria Domenici, Serge N. Schiffmann and Felicita Pedata

Minocycline: Neuroprotective Mechanisms in Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 10
Page: 679-686
Author(s): M. Thomas and W. D. Le

Neurokinin Peptides and Neurokinin Receptors as Potential Therapeutic Intervention Targets of Basal Ganglia in the Prevention and Treatment of Parkinsons Disease

Journal: Current Drug Targets
Volume: 5
Page: 197-206
Author(s): L.- W. Chen, K. K.L. Yung and Y S Chan